Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.34 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.34 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.34 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2420881 | 0.88 | ALDH1A1 (0.44) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL2422987 | 0.86 | ALDH1A1 (0.50) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL13082248 | 0.83 | ALDH1A1 (0.47) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL2423932 | 0.83 | ALDH1A1 (0.47) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL2420676 | 0.83 | ALDH1A1 (0.47) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL3766011 | 0.82 | ALDH1A1 (0.39) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL6579887 | 0.82 | ALDH1A1 (0.43) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL2008231 | 0.81 | ALDH1A1 (0.55) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL3759809 | 0.81 | ALDH1A1 (0.39) | ALDH1A1GLATDP1TP53TSHR | |
| SCHEMBL6579890 | 0.80 | KMT2A (0.45) | ALDH1A1GLATDP1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7960483-B2 | Adamantane derivative, composition comprising the derivative, and optical and electronic member using the composition | IDEMITSU KOSAN CO., LTD. (JP) | 2011-06-14 | — | — | US | disclosed |
| US-20090137775-A1 | ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20090062481-A1 | ADAMANTANE DERIVATIVE, COMPOSITION COMPRISING THE DERIVATIVE, AND OPTICAL AND ELECTRONIC MEMBER USING THE COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1985617-A1 | ADAMANTANE DERIVATIVE, COMPOSITION COMPRISING THE DERIVATIVE, AND OPTICAL AND ELECTRONIC MEMBER USING THE COMPOSITION | Idemitsu Kosan Co., Ltd. (JP) | 2008-10-29 | — | — | EP | disclosed |
| EP-1930327-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-06-11 | — | — | EP | disclosed |
| EP-1923416-A1 | ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM | Idemitsu Kosan Co., Ltd. (JP) | 2008-05-21 | — | — | EP | disclosed |
| JP-2006307062-A | EPOXY RESIN COMPOSITION AND OPTOELECTRONIC MEMBER USING THE SAME | IDEMITSU KOSAN CO LTD | 2006-11-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137774-A1 | ADAMANTANE DERIVATIVE, RESIN COMPOSITION CONTAINING SAME, AND OPTOELECTRONIC COMPONENT USING SAME | GJA1, CDH1, OR10J3 | ALDH1A1 154/4885GLA 2100/4885TDP1 1871/4885 |
| US-20090137775-A1 | ADAMANTANE DERIVATIVE, EPOXY RESIN, AND OPTICAL ELECTRONIC MEMBER USING RESIN COMPOSITION COMPRISING THEM | ARCN1, MEP1A, EPN1 | ALDH1A1 221/4885GLA 630/4885TDP1 2038/4885 |
| US-20090062481-A1 | ADAMANTANE DERIVATIVE, COMPOSITION COMPRISING THE DERIVATIVE, AND OPTICAL AND ELECTRONIC MEMBER USING THE COMPOSITION | APP, ADAM17, PSD | ALDH1A1 301/4885GLA 481/4885TDP1 728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.